Anlon Healthcare (NSE:AHCL) Accounts Payable: ₹422 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:AHCL Anlon Healthcare Ltd NSE:AHCL
17 GF Score
Price ₹15.05
! 5 Warning Signs
View Full Analysis

What is Anlon Healthcare Accounts Payable?

Anlon Healthcare NSE:AHCL -2.21% 17 Accounts Payable is ₹422 Mil as of Mar. 2026. GuruFocus rates NSE:AHCL with a GF Score™ of 17/100. The stock has 5 warning signs investors should review.

Anlon Healthcare's Accounts Payable for the quarter that ended in Mar. 2026 was ₹422 Mil.

Anlon Healthcare's quarterly Accounts Payable declined from Sep. 2025 (₹166 Mil) to Dec. 2025 (₹0 Mil) but then increased from Dec. 2025 (₹0 Mil) to Mar. 2026 (₹422 Mil).

Anlon Healthcare's annual Accounts Payable declined from Mar. 2024 (₹200 Mil) to Mar. 2025 (₹196 Mil) but then increased from Mar. 2025 (₹196 Mil) to Mar. 2026 (₹422 Mil).


Anlon Healthcare Accounts Payable Related Terms


Anlon Healthcare Accounts Payable Historical Data

* Premium members only.

The historical data trend for Anlon Healthcare's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Anlon Healthcare Accounts Payable Chart

Anlon Healthcare Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
Accounts Payable
152.33 253.27 199.92 196.43 421.92

Anlon Healthcare Quarterly Data
Mar22 Mar23 Mar24 Jun24 Sep24 Dec24 Mar25 Sep25 Dec25 Mar26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 196.43 165.58 0.00 421.92
NSE:AHCL
17GF Score
Anlon Healthcare Ltd NSE:AHCL
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Anlon Healthcare Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of ₹422 Mil mean?
Anlon Healthcare (NSE:AHCL) has a Accounts Payable of ₹422 Mil as of Mar. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Anlon Healthcare and its competitors.
Is Anlon Healthcare's Accounts Payable too high?
Anlon Healthcare's current Accounts Payable is ₹422 Mil. Overall, Anlon Healthcare has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Anlon Healthcare's Accounts Payable compare to ZTS and UTHR?
Anlon Healthcare's Accounts Payable of ₹422 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Drug Manufacturers company?
A good Accounts Payable depends on the Drug Manufacturers industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Anlon Healthcare and its competitors. Anlon Healthcare's current Accounts Payable is ₹422 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Anlon Healthcare stock overvalued right now?
Anlon Healthcare (NSE:AHCL) has a current Accounts Payable of ₹422 Mil. The current Accounts Payable is ₹422 Mil. Anlon Healthcare's overall GF Score™ is 17/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Anlon Healthcare (NSE:AHCL), the current Accounts Payable is ₹422 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Anlon Healthcare Business Description

Other Exchanges 544497:India
Address Kalawad Road, 101/102, Silvercoin Complex, Opposite Crystal Mall, Rajkot, GJ, IND, 360 005
Anlon Healthcare Ltd is a chemical manufacturing company engaged in manufacturing of; (i) high purity advance pharmaceutical intermediates which serves as raw material/ key starting material in the manufacturing of active pharmaceutical ingredients; and (ii) active pharmaceutical ingredients which serves as a raw material for pharmaceutical formulations in preparation of various type of Finished Dosage Formula such as tablet, capsules, ointment, syrup etc, ingredients in nutraceuticals formulations, personal care products and animal health products. Its products spans across the family of pharmaceutical intermediates, active pharmaceutical ingredients, nutraceutical APIs and ingredients for personal care and veterinary API.
17GF Score

Get the complete analysis for NSE:AHCL

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹15.05
Price